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ABSTRACT
A compilation of experimentally verified interactions between HIV-1 and human
proteins allows insights into the intricate interplay between viral and host
proteins on a large scale. We find that HIV-1 predominantly targets rich-clubs,
human proteins that are not only well connected but also strongly intertwined
among each other. These assemblies of proteins putatively serve as an infection
gateway, allowing the virus to take control of the human host by reaching protein
pathways and diversified cellular functions in a pronounced and focused way. In
particular, HIV-1 utilizes its small number of proteins in a combinatorial manner,
exerting a significant influence on pathways that deal with transcriptional,
translational and degradation processes. Surprisingly, the small repertoire of HIV
proteins also interferes loosely with many signaling and regulation pathways,
suggesting that a widespread involvement in such pathways secures the control of
the host cell. Such insights offer novel perspectives to investigate the progression
of HIV infection and potentially can contribute to our abilities to fight this virus.
The determination of webs of protein interactions 1, 2, 3, 4 and protein complexes
5, 6, 7, 8, 9 in many different single and multi-cellular organisms progresses at a fast
pace, peaking in attempts to determine the human interactome in various ways
10, 11, 12, 13, 14. Although such webs of intracellular interactions are increasingly
well characterized, little is known about large-scale maps of protein interactions
between cells. As such, investigating host-pathogen interactions is a crucial step
toward a thorough understanding of an organisms pathogenesis, providing an
essential foundation for the development of effective therapeutic and prevention
strategies to combat diseases. Uetz et al. released the first small map of
computationally inferred physical protein interactions between the human host
and the Kaposi-Sarcoma associated Herpesvirus (KSHV) as well as the
Varicella-Zoster-Virus (VZV) 15. In a different approach Calderwood et al. 16
experimentally determined a map of physical protein interactions between the
Epstein-Barr-Virus and the human host. Recently, Bandyopadhyay et al. 17,
identified subnetworks of virus-host proteins that are expressed at different
stages of the HIV-infection.
Rich-clubs of proteins as viral targets. Here, we utilize a compilation of 1, 199
experimentally verified physical and regulatory interactions between 15 HIV-1
and 904 human proteins that are embedded in a web of 12, 542 connections
between 66, 438 human proteins 14, 18, 19, 20, 21. Among those we identify 341
interactions, representing activating or up-regulating activities of HIV on human
proteins (’positive interactions’), while the data set provides 220 interactions that
reflect the virus inhibiting activities (’negative interactions’).
Considering a graphical depiction of the web of all host-viral interactions in Fig.
1a, we not only see an uneven distribution of the number of interactions viral
proteins are involved in but also observe many host proteins that are targeted by
more than one viral protein. As such, we will show topological features of the
human web that are potential targets of HIV-1 as well as investigate
combinatorial patterns virus employ to take control of the host cell. In contrast to
other protein interaction networks of eukaryotic organisms, such as S. cerevisiae,
C. elegans and D. melanogaster 22, 23 the human interactome is composed of an
oligarchy of highly interacting and intertwined nodes. Such a rich-club
phenomenon 22 is quantified by the fraction of edges among nodes that have at
least a certain number of neighbors k in the actual and randomized networks. As
such, the rich-club coefficient ρ(k) points to the presence of a core of highly
intertwined nodes with degree of at least k if ρ(k) > 1. In the absence of this
phenomenon (i.e. ρ(k) < 1) networks are dominated by many well defined
functional communities which are sparsely connected by highly interacting
proteins 22, 24. In the human interactome we find a strong rich-club signal (i.e.
ρ > 1) among proteins with increasing degree in the human interactome (Fig.
1b). As indicated the absence of any rich-clubs would point to the presence of
loosely connected sub-networks. Therefore, such a network would break into
many disconnected parts 23. In contrast, networks that show rich-club behavior
always keep their integrity by maintaining one connected component. As already
indicated in Fig. 1a, we find one connected component that covers all viral and
human proteins. If the placement of host-pathogen interactions was a random
process, such a network would break into numerous disconnected pieces. We
randomly choose sets of human proteins that are targeted by HIV-1 proteins,
allowing us to find that the presence of a connected component is statistically
significant (P < 10−3). In the same way, we find that the three connected
components in bipartite networks of positive and negative interactions are of the
same significance as well. The features of rich-clubs in the underlying human
interactome are potentially proteomic targets that a pathogen might utilize.
Indeed, we find an enrichment of proteins in rich-clubs that are targeted by
HIV-1. In particular, we find a recurrence of this pattern if we focus on the
subsets of negative and positive interactions (Fig. 1c). As indicated on a
qualitative basis, the number of human host proteins a viral protein targets is not
evenly distributed (Fig. 1a). In fact, we find that Tat, Nef and Vpr - viral proteins
that predominantly interfere with regulatory host processes - work on far more
human proteins than a simple average would suggest (see SOMTable 1). In Fig.
1d, we observe that one viral protein acts on the majority of human proteins,
while a minority is targeted by up to 6 viral proteins, a pattern we also find for
positive and negative interactions. Such distributions roughly decay
exponentially, an inhomogeneity that is visually captured in the graphical
representation of virus-host interactions in Fig. 1a. Assuming that the total
number of HIV-1 proteins reflects the importance and centrality of a targeted host
protein, we expect that the mean number of viral proteins increases in rich-clubs.
Indeed, we find such an increasing trend for the total set of host-virus
interactions as well as positive interactions in Fig. 1d. Although we observe that
negative interactions lack such a correlation, our results suggest that samples of
highly connected and intertwined proteins provide topological features the virus
utilizes as a gateway to take over control over the host cell.
The role of protein pathways as viral targets. Another level of proteomic
organization are protein pathways. As a reliable source, we obtained 913
manually curated pathways from the Protein Interaction Database (PID). As a
result, we not only find that human protein proteins strongly vary in the number
of involved proteins (inset, SOMFig. 1b) but also share proteins to a large extent
(SOMFig. 1a). Emphasizing the role of protein hubs to be involved in numerous
protein pathways (SOMFig. 1b), we anticipate that the pathogen also takes
advantage of this host feature. Indeed, we find that proteins that appear in
rich-clubs of increasing degree appear in an increasing number of pathways (Fig.
2a), a result that also appears in the smaller subset of positive and negative
interactions (SOMFig. 2a). A corollary of this hypothesis suggests that the
comparably small number of human proteins that HIV-1 targets would allow the
virus to reach a larger number of pathways than by chance alone. Although a
justified argument, we find quite the opposite in the inset of Fig. 2a. In fact, the
random selection of targeted human proteins reaches a larger total number of
protein pathways (P < 10−3) than in the actual case. Analogously, we find the
same results for human proteins that are either positively or negatively influenced
by the virus (SOMFig. 2b), indicating the relevance of a focused placement of
viral links in the human host pathways that allow to take over control of the host
cell to the largest extent. On a different note, we hypothesize that the
predominance of targeting hubs as potential mediators of a viral infection also
has an aspect of variety. Assuming that the virus tries to optimize its pathway
’reach’, we expect that HIV-1 might target proteins, that are involved in many
different pathways. As a measure of diversity, we define the pathway
participation coefficient: if a protein predominantly interacts with partners that
are members of the same pathway, this measure tends toward 1, while the
opposite holds if the interaction partners of the protein in question are distributed
among many different pathways. Accounting for all human proteins, we largely
observe that interactions of a single protein occur in a variety of pathways, while
relatively few interactions are confined to a small number of pathways (Fig. 2b).
Focusing on the subsets of targeted human proteins, we observe a reinforcement
of the initial diversity signal. Supporting our initial hypothesis, this result
indicates that the virus aims to reach into as many pathways as possible by
diversifying the reach of host-pathogen interactions to the largest extent.
Combinatorial utilization of viral proteins. As mentioned previously, the
observation that a bipartite network of interactions between HIV-1 and human
proteins is one connected component strongly suggests that combinations of viral
proteins target the same subsets of human proteins. In Fig. 3a, we construct a
network, linking viral proteins if they share a subset of human proteins they
target together. In particular, we weight each link by the size of the shared subset
of targeted human proteins. We observe that Tat dominates such a network,
largely working the same targets predominantly in combination with Vpr and
Nef as well as Vif, while there also exists a weaker link between Vpr and Nef.
The richness of the underlying data also allows us to elucidate such combinations
of regulatory links between viral and human proteins that share similar functions.
In Fig. 3b, we observe that Tat down-regulates subunits of the 26S particle of the
human proteasome in combination with Vif. This observation largely indicates
the virus objective to mute the apparatus which removes disposed proteins,
activities that potentially impair activities to produce new viral protein particles.
In the same way, HIV-1 interferes with immunological responses upon an
infection. As such, human proteins that participate in immunological pathways
such as interleukines and major histocompatibility complexes (MHC) are largely
controlled by a combination of viral proteins. Interleukines - proteins that play a
pivotal role in activating signal pathways for the stimulation of B and NK cells 25
- are largely controlled by Nef, Tat and Vpr (Fig. 3c). A different class of
proteins involved in defensive activities, MHC molecules, play a vital role in the
complex immunological dialogue. All MHC molecules receive polypeptides
from inside the cells and display them on the cells exterior surface for
recognition by T cells. An interaction with the T-cells triggers an immune
response if polypeptides of foreign origin are identified 26. As such, one of the
objectives of the virus is to silence such pathways, preventing the release of
signals of a cellular disturbance, as exemplified by a strong inhibiting and
binding activity on MHC subunits by Nef and Tat. Similarly, classes of
interferones can trigger an immune response to a RNA virus infection by their
secretion when abnormally large amounts of dsRNA are found in a cell, leading
to the attenuation of the cells ability to initiate translation. This induced shortage
of protein production not only interferes with viral replication, but also inhibits
normal cell ribosome function, killing both the virus and the host cell.
Furthermore, interferones lead to the up-regulation of MHC I and therefore to an
increased presentation of viral peptides to cytotoxic CD8 T cells, as well as to a
change in the proteasome which leads to increased production of MHC I
compatible peptides. While MHC I subunits are predominantly blocked by Tat
and Nef, IFN-γ is controlled by capsid, matrix, Nef, Tat and Vpr (data not
shown). Interferones can also cause increased p53 27 activity in virus infected
cells, acting as inducers, promoting apoptosis and limiting the ability of the virus
to spread 28, 29. Indeed, we find that Tat in putative combination with Nef, Vpr
and reverse transcriptase inhibits p53 and other tumor suppressor genes and
oncogenes (Fig. 3d), that play important roles in other signaling pathways. In
particular, we observe that NF-κB is largely activated by this combination of
viral proteins, indicating a particular role of the NF-κB pathway as a focus of
virus interference and tumor emergence. Recently, reports indicated that this
pathway does not only play a primary role in many different types of cancer, but
can easily be activated by low mutational activity of the underlying pathway
genes 30, 31. Similarly, we observe that especially combinations of Tat, Nef and
Vpr predominantly activate an array of protein kinases. Among others, we find a
prominent protagonists such as phoshatidylinositol-3-kinase (PI3K) where
mutations in the latter protein are frequent in many breast cancers 32, 33, 34,
implicating that both the NF-κB and PI3K pathway are pivotal not only for
tumor emergence but also for the invasion process of HIV-1.
Entanglement of pathways. While we focused on single proteins in the
previous section, we take the next step by determining a network of pathways if
they share proteins that interact with the virus. Utilizing pathways from the
Pathway Interaction Database we assess the significance of weighted links
between attacked protein pathways by a two-tailed Fisher’s test 35. Applying a
threshold of P < 10−3 we find that the resulting web largely breaks into four
functionally distinct parts (Fig. 4). In particular, densely connected components
refer to pathways that play a role in transcription and mRNA processing activities
as well as degradation and translational activities. As indicated in Fig. 3, HIV-1
utilizes its proteomic material in a combinatorial way to interact with proteins
that are involved in such functions and to secure the production of further virus
particles. Although we found hints that HIV-1 also interacts with a few
interesting signaling proteins (Fig. 3d), we surprisingly find a large and loosely
connected component in the pathway network, composed of numerous prominent
signaling and regulation pathways, clearly suggesting that the virus needs to
interact with a considerable number of such pathways to seize control of the cell.
As indicated before, we also find that positive ties largely govern transcription
and mRNA processing pathways, while negative interaction influence entirely
degradation pathways (data not shown). In SOMTable 2, we list all these
pathways we show in Fig. 4. In particular, we find a pathway that deals with
signaling events involving hepatocyte growth factor receptor c-met (#85) to be a
major hub. In particular, the proteins which are targeted by the virus are largely
prominent signaling proteins such as MAP kinases and PI3K, which also appear
in many other signaling and regulation pathways. As such, these observations
suggest that the proteins that are in the intersection of many different pathways
are key players for understanding the ways HIV gains control of the human host.
Discussion. HIV-1 invokes intricate processes with a remarkably low number of
proteins to take control of the human host cell. In particular, the subtle structure
of the human interactome reveals sites that are not only topologically important,
but also are significantly targeted by the HIV-virus. Compensating for its low
number of proteins, combinations of pathogen proteins allow the virus to
simultaneously act on many different human proteins. Such subsets reach into
functional entities assuring largest diversity in a focused way. Remarkably, such
combinations of virus proteins interfere with a variety of different pathways in
order to take control of the human host, ultimately utilizing it for the virus own
survival. Therefore, untangling the intricate web of intertwined pathways is of
utmost importance for a thorough understanding of the virus pathogenesis. In the
light of these observations proteins that are shared by a large number of relevant
pathways might be key players to understand the subtle molecular strategies a
virus employs to take over control of a host cell. In addition, the analysis of the
entanglement of signaling and regulation pathways may uncover molecular and
functional Achilles heels that might help to hamper the virus in a systematic way
36. Therefore, a web of well defined host-pathogen interactions offers the
opportunity to consider viral systems as naturally perturbed biological systems
that can be utilized to identify and disentangle relevant pathways in different
cellular contexts, ultimately allowing us to eradicate other pathogen driven
diseases that plague human kind.
1 Materials and Methods
Human HIV Protein Interactions
We utilize a compilation of 1, 199 experimentally obtained protein interactions
between the human host and HIV-1, accounting for interactions that have been
found in vital cells in the human immune system such as helper T cells,
macrophages and dendritic cells
(http://www.ncbi.nlm.nih.gov/RefSeq/HIVInteractions/). 341 interactions
describe activation and/or up-regulating activities of HIV on human proteins
(’positive’ interactions), and 220 interactions depict inhibiting activities of the
virus (’negative’ interactions).
Human Protein Interactions and Pathways
Collecting pairwise protein interactions in H. sapiens from public databases 18, 20
and experimental results 11, 14, 19, 21, we obtain a network of 12, 542 proteins
embedded in 66, 438 physical interactions. As a source of reliable human protein
pathway information we utilized 913 annotated pathways from the Pathway
Interaction Database (http://pid.nci.nih.gov).
Rich-Club Coefficient
The so-called rich-club phenomenon is quantitatively defined by the rich-club
coefficient Φ(k) 22. Denoting by E≥k the number of edges among the N≥k nodes
which have at least k interaction partners, the rich-club coefficient is expressed as
Φ(k) =
2E≥k
N≥k(N≥k − 1) , (1)
where N≥k(N≥k − 1)/2 represents the maximally possible number of edges
among the N≥k nodes. An appropriate choice for normalizing the rich-club
coefficient is provided by the ratio
ρ(k) =
Φ(k)
Φr(k)
, (2)
where Φr(k) is the rich-club coefficient of a random network with the same
degree distribution P (k). The choice of pairs of links, whose end nodes are
exchanged, allows us to obtain such a randomized network where the degree
distribution is preserved 22, 37. In order to have a reasonably large ensemble, we
repeat the randomization process 10, 000 times. Binning nodes according to their
degrees k we obtain a degree dependent mean value of the rich-club coefficient
by averaging over all ρ’s in each bin. A ratio larger than one, ρ > 1, is the actual
evidence for the presence of a rich-club phenomenon, an increase in the
interconnectivity of large degree nodes compared to the random case. This
process is well displayed by the presence of an oligarchy of highly interacting
nodes that are well connected among each other. A ratio ρ(k) < 1 points to a
lack of interconnectivity among large degree nodes which are separated in
distinguishable modules.
Enrichment
Each rich club where each protein has at least k interactions N≥k is represented
as a subset of all proteins N in the underlying network, N≥k ∈ N . In order to
obtain an estimate if proteins targeted by the virus are overrepresented in a
rich-club, we calculate the corresponding fraction of attacked proteins
fa,≥k = |Na,≥k|/|N≥k| in the underlying rich club N≥k. As a null hypothesis, we
assume that the virus targets human proteins randomly. Determining the
randomized fraction of targeted proteins fr,a,≥k, we define Ea,≥k = fa,≥k/fr,a,≥k
as the enrichment of attacked proteins in a rich club. Averaging E over 10, 000
randomizations rich clubs are enriched with attacked proteins if E > 1 and vice
versa.
Pathway Participation Coefficient
For each protein that is part of at least one pathway, we define the pathway
participation coefficient of a protein i, as
Pi =
N∑
s=1
(
nis∑N
s=1 nis
)2, (3)
where nis is the number of links protein i has to proteins in pathway s out of N
total pathways. If a protein predominantly interacts with partners that are
members of the same pathway, we find that P tends to 1, while the opposite
holds if the interaction partners are distributed among many different pathways.
Significance of Links between attacked Pathways
Determining the significance of links between pathways if they share proteins
that interact with viral proteins, we form a 2× 2 contingency table for each pair
of pathways. In particular, we define α as the number of shared proteins under
attack by the virus while β is the number of remaining proteins in a pair of
overlapping pathways. Analogously, we define γ as the number of attacked
proteins and δ as the number of remaining proteins in all the other pathways 35.
The probability of obtaining any such set of values randomly is given by the
hypergeometric distribution:
p∗ =
(
α+β
α
)(
γ+δ
γ
)
(
N
α+γ
) , (4)
where N = α + β + γ + δ. In order to investigate the two tails of the underlying
distribution we construct all possible contingency tables by keeping the sum of
rows and columns constant. The P -value to reject the null hypothesis being the
independence of rows and olumns in the contingency table is the sum of the
probabilities pi, of all contingency tables i where pi ≤ p∗.
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Figure 1: (a) Graphical representation of the network of all protein interactions
between HIV-1 and human proteins. (b) The distribution of the mean rich-club
coefficient ρ significantly increases with higher numbers of interaction partners
in the human protein interaction network, suggesting the presence of an
oligarchy of highly interacting and intertwined proteins. (c) Determining the
enrichment of all human proteins that are targeted by HIV-1, we find that
especially highly connected proteins are predominantly affected by the virus.
Considering only human host proteins that are either positively or negatively
influenced by the virus we observe similar trends. (d) As another biologically
significant characteristic of the viral infection, we observe that host proteins can
be targeted by more than one viral protein, results that are consistent with the
smaller subsets of positive and negative interactions. Calculating the mean
number of targeting viral proteins in rich-clubs, we obtain increasing numbers
toward higher connected, while we find almost no correlation for host proteins
that are negatively influenced by the virus (inset).
Figure 2: (a) Another level of proteomic organization are protein pathways. All
human proteins that are targeted by the virus are part of 592 protein pathways
(inset, dotted line). Randomizing human protein sets that are attacked by the
virus we find significantly larger numbers of affected pathways, indicating the
focused placement of host-pathogen interactions to affect a distinct set of
pathways (inset, P < 10−3). (b) A low value of the pathway participation
coefficient represents the observation that the interactions of a protein are present
in many different pathways and vice versa. Considering all human proteins, we
obtain a maximum around low values. Focusing on subsets of targeted human
proteins we find that the original signal is significantly reinforced.
Figure 3: (a) We connect a pair of HIV-1 proteins if both viral proteins target the
same set of human proteins. While the size of nodes indicates the number of
links the corresponding node is involved in, the thickness of edges refers to the
number of co-targeted human proteins, pointing to strong links between Tat, Vpr,
Nef and Vif. Assuming that these links mediate biological significance, we
elucidate functional sub-networks that emerge from co-regulating human
proteins by combinations of HIV proteins. In particular, (b) shows that Tat
strongly inhibits subunits of the 26S particle of the human proteasome supported
by interactions involving Vif. (c) Human proteins that participate in
immunological pathways such as interleukines and major histocompatibility
complexes are largely affected by a combination of viral proteins, predominantly
involving Tat, Nef and Vpr. (d) Tat again plays an important role in stimulating
oncogenes that are involved in signal transduction pathways. In particular, we
observe that a combination of reverse trancriptase, Vpr and Nef bind p53 while
Tat down-regulates this prominent oncogene.
Figure 4: Determining a network of pathways we place a weighted link between
pathways if they share proteins that are attacked by the virus. In particular, the
size of nodes refers to the number of targeted proteins in the pathway, while the
strength of edges indicates the number of such proteins both pathways share, and
numbers point to pathways described in SOMTable 2. Considering significantly
weighted links (P < 10−3), we observe that the network of attacked pathways is
largely composed of four connected components. The densely connected
components refer to pathways that play a role in transcription events and mRNA
processing, translational and degradation activities. In contrast, the largest
component is a surprisingly loose assembly of signaling and regulation
pathways, suggesting that the virus needs to interact with a considerable number
of such pathways to seize control of the cell.
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